Gain Therapeutics, Inc. (NASDAQ:GANX) Given Average Recommendation of "Moderate Buy" by Analysts
MarketBeat
Absci Corporation (NASDAQ:ABSI) Given Average Recommendation of "Moderate Buy" by Brokerages
MarketBeat
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Rating of "Moderate Buy" from Analysts
MarketBeat
InterDigital, Inc. (NASDAQ:IDCC) Receives Average Recommendation of "Moderate Buy" from Analysts
MarketBeat
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Average Rating of "Moderate Buy" by Analysts
MarketBeat
